Agenus Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$3.58

+0.00 (+0.00%)

As of May 16, 9:41 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 7 88%

Hold 1 13%

Sell 0 0%

Price Target

Analyst Price Target +965.1% upside

Low Target $23.34

Average Target $38.13

High Target $40.06

Current Price $3.58

Current
$3.58

Target
$38.13

$23.34 $38.13 avg $40.06

Scenario Analysis

Bear Case

$23.34

552.0%

Low target

Base Case

$38.13

+965.1%

Avg target

Bull Case

$40.06

+1,019.0%

High target

Risk/Reward

1.8x

Balanced

Price in Context

52-Week High

$7.34

-51.2% from high

52-Week Low

$2.71

+32.1% from low

Target vs 52W High

$38.13

+419.5% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+22.4%
AMGN Amgen Inc	Hold	44	48%	$190.87	-41.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+179.9%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+0.3%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.0%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-64.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-21.7%
BIIB Biogen Inc	Buy	43	56%	$91.45	-52.6%